Caricamento...
Cost-Effectiveness of Treatment Strategies for BRAF-Mutated Metastatic Melanoma
PURPOSE: Genetically-targeted therapies are both promising and costly advances in the field of oncology. Several treatments for metastatic melanoma with a mutation in the BRAF gene have been approved. They extend life but are more expensive than the previous standard of care (dacarbazine). Vemurafen...
Salvato in:
| Autori principali: | , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Public Library of Science
2014
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4157865/ https://ncbi.nlm.nih.gov/pubmed/25198196 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0107255 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|